Visceral Leishmaniasis: Kala-azar

Affiliations

¹ Pathology Department, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
² Department of Infectious Diseases, Pediatric's Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Case Reports

Moeinadin Safavi et al. Diagn Cytopathol. 2021 Mar.

. 2021 Mar;49(3):446-448.

doi: 10.1002/dc.24671. Epub 2020 Nov 22.

¹ Pathology Department, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
² Department of Infectious Diseases, Pediatric's Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

No abstract available

References

1. Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):S7-S16.
1. Szeto O, Finkelstein A, Wei XJ, Aguero-Rosenfeld M, Shi Y. Leishmania amastigotes in the ascites of a HIV-positive patient. Diagn Cytopathol. 2014;42(5):428-430.
1. Kumar A, Pandey SC, Samant M. A spotlight on the diagnostic methods of a fatal disease visceral Leishmaniasis. Parasite Immunol. 2020;42(10):e12727.
1. Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and globalestimates of its incidence. PLoS One. 2012;7(5):e35671.
1. Mohebali M. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol. 2013;8(3):348-358.